With the increasing popularity of large language models, concerns over content authenticity have led to the development of myriad watermarking schemes. These schemes can be used to detect a machine-generated text via an appropriate key, while being imperceptible to readers with no such keys. The corresponding detection mechanisms usually take the form of statistical hypothesis testing for the existence of watermarks, spurring extensive research in this direction. However, the finer-grained problem of identifying which segments of a mixed-source text are actually watermarked, is much less explored; the existing approaches either lack scalability or theoretical guarantees robust to paraphrase and post-editing. In this work, we introduce a unique perspective to such watermark segmentation problems through the lens of epidemic change-points. By highlighting the similarities as well as differences of these two problems, we motivate and propose WISER: a novel, computationally efficient, watermark segmentation algorithm. We theoretically validate our algorithm by deriving finite sample error-bounds, and establishing its consistency in detecting multiple watermarked segments in a single text. Complementing these theoretical results, our extensive numerical experiments show that WISER outperforms state-of-the-art baseline methods, both in terms of computational speed as well as accuracy, on various benchmark datasets embedded with diverse watermarking schemes. Our theoretical and empirical findings establish WISER as an effective tool for watermark localization in most settings. It also shows how insights from a classical statistical problem can lead to a theoretically valid and computationally efficient solution of a modern and pertinent problem.

Cancer, a leading cause of death globally, occurs due to genomic changes and manifests heterogeneously across patients. To advance research on personalized treatment strategies, the effectiveness of various drugs on cells derived from cancers (`cell lines') is experimentally determined in laboratory settings. Nevertheless, variations in the distribution of genomic data and drug responses between cell lines and humans arise due to biological and environmental differences. Moreover, while genomic profiles of many cancer patients are readily available, the scarcity of corresponding drug response data limits the ability to train machine learning models that can predict drug response in patients effectively. Recent cancer drug response prediction methods have largely followed the paradigm of unsupervised domain-invariant representation learning followed by a downstream drug response classification step. Introducing supervision in both stages is challenging due to heterogeneous patient response to drugs and limited drug response data. This paper addresses these challenges through a novel representation learning method in the first phase and weak supervision in the second. Experimental results on real patient data demonstrate the efficacy of our method (WISER) over state-of-the-art alternatives on predicting personalized drug response.

This paper presents a novel semantic representation, WISeR, that overcomes challenges for Abstract Meaning Representation (AMR). Despite its strengths, AMR is not easily applied to languages or domains without predefined semantic frames, and its use of numbered arguments results in semantic role labels, which are not directly interpretable and are semantically overloaded for parsers. We examine the numbered arguments of predicates in AMR and convert them to thematic roles that do not require reference to semantic frames. We create a new corpus of 1K English dialogue sentences annotated in both WISeR and AMR. WISeR shows stronger inter-annotator agreement for beginner and experienced annotators, with beginners becoming proficient in WISeR annotation more quickly. Finally, we train a state-of-the-art parser on the AMR 3.0 corpus and a WISeR corpus converted from AMR 3.0. The parser is evaluated on these corpora and our dialogue corpus. The WISeR model exhibits higher accuracy than its AMR counterpart across the board, demonstrating that WISeR is easier for parsers to learn.

In this report we examine the effectiveness of WISER in identification of a chemical culprit during a chemical based Mass Casualty Incident (MCI). We also evaluate and compare Binary Decision Tree (BDT) and Artificial Neural Networks (ANN) using the same experimental conditions as WISER. The reverse engineered set of Signs/Symptoms from the WISER application was used as the training set and 31,100 simulated patient records were used as the testing set. Three sets of simulated patient records were generated by 5%, 10% and 15% perturbation of the Signs/Symptoms of each chemical record. While all three methods achieved a 100% training accuracy, WISER, BDT and ANN produced performances in the range of: 1.8%-0%, 65%-26%, 67%-21% respectively. A preliminary investigation of dimensional reduction using ANN illustrated a dimensional collapse from 79 variables to 40 with little loss of classification performance.

Aging gets a bad rap. But disease, decline and discomfort is far from the whole story. Dilip Jeste, professor of psychiatry and neuroscience at UC San Diego and director of the UCSD Center for Healthy Aging, is challenging us to take another look. In conversation with Nautilus, Jeste points out that some things get better with age, like the ability to make decisions, control emotions, and have compassion for others--in other words, we get wiser with age. The challenge to aging well, he argues, is to be optimist, resilient and pro-active, allowing the benefits of age to shine through.

With the launch of its new Native and Emerging Technologies (NET) group, Hearst Corporation has made a big push to keep up with emerging technologies such as augmented reality, artificial intelligence (AI) and voice-controlled search. But the century-old company isn't just playing around with cutting-edge tools--rather, Hearst is using them to develop a New Age marketing and analytics workflow that delivers real business value. That's according to Phil Wiser, CTO at Hearst, who spoke with eMarketer's Maria Minsker about how the company is making the old work with the new. Phil Wiser: The group originated because we noticed a shift to voice-based interfaces, especially for search. We know that a meaningful percentage of online searches shifted to voice over the past year.